Baird analyst David Rescott initiates coverage on Boston Scientific (NYSE:BSX) with a Outperform rating and announces Price Target of $59.
Baird analyst David Rescott initiates coverage on Boston Scientific (NYSE:BSX) with a Outperform rating and announces Price Target of $59.